Clinical Trial Update: A Study of Intravenous Mircera in Participants With Chronic Renal Anemia Who Are on Dialysis [Phase 3]

View source ↗

Summary

Phase 3 study of intravenous Mircera for chronic kidney disease-related anemia in dialysis patients has completed. Results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease-related Anemia

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2016-03-15